The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]

Johannes W G Jacobs; Maarten Boers; John R. Kirwan; Johannes W J Bijlsma

doi:10.1002/art.22049

The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]

Johannes W G Jacobs^*, Maarten Boers, John R. Kirwan, Johannes W J Bijlsma

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	2031-2032
Number of pages	2
Journal	Arthritis and Rheumatism
Volume	54
Issue number	6
DOIs	https://doi.org/10.1002/art.22049
Publication status	Published - 1 Jun 2006

Access to Document

10.1002/art.22049

Handle.net

Persistent link

Cite this

@article{5a173d9260484df0a79fa07951677e9b,

title = "The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]",

author = "Jacobs, {Johannes W G} and Maarten Boers and Kirwan, {John R.} and Bijlsma, {Johannes W J}",

year = "2006",

month = jun,

day = "1",

doi = "10.1002/art.22049",

language = "English",

volume = "54",

pages = "2031--2032",

journal = "Arthritis and Rheumatism",

issn = "0004-3591",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk

T2 - Comment on the editorial by Harris [1]

AU - Jacobs, Johannes W G

AU - Boers, Maarten

AU - Kirwan, John R.

AU - Bijlsma, Johannes W J

PY - 2006/6/1

Y1 - 2006/6/1

UR - http://www.scopus.com/inward/record.url?scp=33745053316&partnerID=8YFLogxK

U2 - 10.1002/art.22049

DO - 10.1002/art.22049

M3 - Letter (Academic Journal)

C2 - 16732571

AN - SCOPUS:33745053316

SN - 0004-3591

VL - 54

SP - 2031

EP - 2032

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 6

ER -

The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]

Access to Document

Handle.net

Other files and links

Cite this